The biggest artificial intelligence themes for the next decade

Waste management and healthcare among big topics

clock • 4 min read

Artificial intelligence (AI) firms have continued, in the main, to be among the market leaders in the last quarter, with share prices of some of the leading AI beneficiaries falling and then recovering as it became clear the US was changing tack on monetary policy.

This change, which in all likelihood will see interest rates cut rather than raised, should extend the rally we have seen recently, with global equities buoyed by expectations of monetary easing in the US, broad resilience in corporate earnings and hopes the US and China will be able to come to some resolution on their trade dispute. Lower interest rates are good for long duration assets like quoted artificial intelligence companies, as larger-than-expected rate hikes pose the biggest threat to such businesses. 'A marriage between humans and machines': How AllianzGI is embracing artif...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot